Posted : Tuesday, July 23, 2024 10:23 AM
-
Ascada Research is inviting individuals positive for Respiratory Syncytial Virus who are also at high risk (as defined below) to participate in a clinical study.
This study is evaluating a potential RSV treatment option and participants in the study will be randomly selected either to receive the investigational treatment or a placebo.
Study volunteers will be expected to attend approximately 6 in-office visits at our Fullerton location over the span of 33 days.
All study-related treatments and procedures are provided at no-cost to participants.
Participation is always voluntary, and individuals may discontinue participation at any point during the study.
Qualified Participants Include:
• Adults 18 years or older
• Adults who are at high risk of complications from RSV [adults who either 1) have Congestive Heart Failure, 2) have Asthma, or 3) have COPD or 4) are 65 years or older]
• Adults who started experiencing RSV symptoms no more than 3 days ago (such as cough, fever, runny nose, headache, fatigue, etc.
)
• Adults who are RSV positive (RSV testing provided at no-cost for pre-qualified individuals)
✅ CLICK HERE TO SIGN UP ✅
Ascada Research
Open M-F 8:00am-4:30pm
Fullerton: (657)-214-3679
www.
AscadaResearch.
org
• Phone : (657) 214-3679
• Location : Garden Grove,CA
• Post ID: 9138011107
Posted : Wednesday, September 04, 2024
Posted : Wednesday, September 04, 2024
Posted : Wednesday, September 04, 2024
Posted : Tuesday, September 03, 2024
Posted : Friday, August 30, 2024